Key facts
- Finasteride, a drug for hair loss and prostate issues, was not included in Donald Trump's recent medical reports.
- An expert expressed concern over the omission, suggesting potential lack of transparency.
- The expert stated that the absence of finasteride raises questions about what other information is not being revealed.
Donald Trump's latest medical reports have omitted any mention of finasteride, a medication commonly used for hair loss and benign prostatic hyperplasia. This absence has prompted concerns from experts regarding the completeness and transparency of the disclosed medical information. One expert highlighted that the exclusion of finasteride raises significant questions about whether other relevant details might also be withheld from public view. The implications of this omission are currently unclear, but it points to a potential lack of full disclosure in the provided medical documentation.